Thursday, April 16, 2026

Log into Keith’s $5,000 AI Signals Trading system

Editor's Note: Recently, we met with a fintech CEO. He told us about a system he created after tracking $29 billion. A website that shows you the day's best trades, by using AI to detect which of 2,467 stocks could soon jump. At first, it sounded like "pie in the sky" – until we saw the results. Read on...


Dear Reader,

Today, we're sharing a new AI "trade detector" for 2026.

Each morning, it shows you the most profitable trades taking shape – 90 minutes before they occur.

See how it works – right now – on 2,467 different stocks:

Last year alone, it returned 124% in a backtest, crushing the market nearly 3-fold in a model portfolio.

We developed this system by using AI on a new "micro" level most people have never seen before. It's the newest feature of a system that helped us call last year's crash and rally (even posting a free pick that doubled in 4 months).

I urge you to try our new system (no purchase required) before April 22... to prepare for an echo of the late 1990s set to slam stocks this month.

So far, our 2026 beta results have been remarkable...

37.7% gain in 33 days on (GNRC)

22% gain in 6 days on (ALB)

21.4% gain in 4 days on (DECK)

21.3% gain in 30 days on (HWM)

20.2% gain in 15 days on (SDNK)

18.3% gain in 16 days on (GRMN)

15.4% gain in 7 days on (TPR)

15.2% gain in 7 days on (EFX)

15% gain in 2 days on (DASH)

14.9% gain in 30 days on (LMT)

14.2% gain in 5 days on (TER)

14% gain in 2 days on (DDOG)

13.9% gain in 1 day on (PAYC)

13.4% gain in 6 days on (EME)

12.6% gain in 8 days on (FCX)

11.9% gain in 1 day on (ALGN)

...and dozens more

We value this new AI system at $5,000.

But today, you can claim free access here(no purchase required).

Regards,

Keith Kaplan
CEO, TradeSmith


 
 
 
 
 
 

Additional Reading from MarketBeat

These are the 3 Biggest AI Winners and Losers of 2026

By Leo Miller. First Published: 4/13/2026.

Glowing fiber optic cables connected to a data center network switch.

Key Points

  • AI is beating down software stocks, but the losses hitting one name really stick out
  • Optical transceivers are having a heyday in AI data centers, and this small name is skyrocketing
  • A memory chip stock that took off last year isn't slowing down in 2026
  • Special Report: The Biggest IPO Ever: Claim Your Stake Today

In 2026, the market has clearly established which stocks it believes are artificial intelligence (AI) winners and losers. Software names in general have taken a big hit, but some are being affected by AI-driven fears more than others. Meanwhile, certain hardware stocks are putting up monstrous returns, even as huge names like NVIDIA (NASDAQ: NVDA) have stalled.

Below are the market’s biggest AI winners and losers so far in 2026, focusing on U.S. tech stocks with market capitalizations above $10 billion.

Applied Optoelectronics Rides the Transceiver Wave

The REAL Reason Trump is Invading Iran (Ad)

For a moment…

Forget about Trump’s ties to Israel.

Forget about reports of Iran’s nuclear program.

Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.

Click here to find out what it is.tc pixel

Among U.S. technology stocks with market capitalizations above $10 billion, Applied Optoelectronics (NASDAQ: AAOI) has been the market’s best performer so far in 2026. Shares are up more than 300%. Throughout the year, Applied repeatedly announced that a major hyperscale customer is ordering its optical transceivers.

Applied’s rise comes as investors rush into optical transceiver stocks. Notably, Lumentum (NASDAQ: LITE), a much larger player in the space, has seen its share price climb more than 130% in 2026. Optical transceivers are increasingly in demand for data-center networking because they allow companies to process more data at high speeds. Beginning 2026 with a market capitalization of about $2.4 billion, this trend has disproportionately benefited Applied Optoelectronics.

With Applied’s market capitalization now approaching $12 billion and its last 12 months of sales at $445 million, investors are pricing in substantial future growth. Applied is expanding rapidly, with revenues rising 84% year over year (YOY) in 2025.

Analysts expect that growth to accelerate, projecting sales to increase nearly 110% in 2026. They also see the firm turning profitable on an adjusted basis for the first time since 2018, forecasting adjusted earnings per share (EPS) above $0.80 compared with a $0.26 loss per share in 2025.

Software Sell-Off Hits Atlassian From Multiple Angles

Atlassian (NASDAQ: TEAM) has been among the market’s hardest-hit software stocks amid fears of AI disruption. Shares are down more than 60% in 2026. Unlike many software companies, a large part of Atlassian’s customer base is software developers. AI coding tools have made software development significantly easier, which could reduce the number of developers companies need.

Atlassian uses a seat-based pricing model, charging customers based on the number of employees who access its tools. If customers need fewer software developers, that directly pressures Atlassian’s seat-based revenue. Markets may also fear that customers can quickly develop applications using AI tools that replicate functions currently enabled by Atlassian’s products.

For these reasons, the rise of AI coding tools has hit Atlassian harder than many software peers. Still, Atlassian’s growth remains solid, with revenues rising more than 23% YOY last quarter. The company’s risks, however, raise significant questions about whether that growth can be sustained. The market is currently pricing Atlassian as a firm that will see little, if any, long-term free cash flow growth; its last 12 months of free cash flow fell 7% in the most recent quarter.

SanDisk’s Incredible Run Continues

Despite SanDisk (NASDAQ: SNDK) jumping a whopping 559% in 2025, investors have continued to drive the stock higher. Shares are up more than 250% in 2026, making SanDisk one of the market’s top-performing AI-related stocks. Since going public in February 2025, SNDK has delivered an astonishing return of over 2,200%.

SanDisk’s surge is being driven by rapid demand for memory and storage chips in data centers. SanDisk is a leading producer of NAND flash memory, a relatively concentrated industry where supply is extremely tight. That tight supply has allowed SanDisk to raise prices significantly.

TrendForce projects that NAND flash prices will rise 70% to 75% quarter over quarter (QoQ) in Q2 2026, after estimated QoQ increases of 85% to 90% in Q1 2026. If those forecasts hold, they imply NAND flash price increases of roughly 215% to 233% through the first six months of the year — which helps explain SanDisk’s dramatic gains. Forecasters also expect SanDisk’s adjusted EPS to more than double to over $14 in the coming quarter, up from $6.20 last quarter on an adjusted basis.

A Software Recovery Is Unlikely to Come Easily

Applied Optoelectronics, Atlassian and SanDisk sit at opposite ends of the spectrum in how the market views AI’s impact on their businesses. Analysts continue to point to a potential recovery for Atlassian, with many projecting 100% upside or more. While a rebound is possible, the pace of new AI tool releases is unlikely to slow in the near term. That continued innovation could prolong the pronounced fears weighing on many software stocks.


Additional Reading from MarketBeat

3 Oversold Healthcare Stocks to Buy After Jobs Data

By Chris Markoch. First Published: 4/13/2026.

An empty, modern hospital hallway and an open patient room containing a bed and medical equipment.

Key Points

  • Strong March job growth in healthcare is reinforcing the sector’s defensive appeal, creating opportunities to buy high-quality stocks after recent pullbacks.
  • HCA Healthcare and Tenet Healthcare stand out for their scale, earnings strength, and institutional support, with both stocks rebounding from oversold levels.
  • Universal Health Services offers turnaround potential and added upside from its Talkspace acquisition, positioning it for recovery as sentiment improves.
  • Special Report: The Biggest IPO Ever: Claim Your Stake Today

The March jobs report released on April 3 showed an impressive 178,000 jobs were created. Of that number, 76,000 were in the healthcare sector. This reversed the decline in healthcare jobs posted the prior quarter, with most gains coming in hospitals and ambulatory care services.

For investors, the report reinforces the case for select stocks in this space, particularly when they seek defensive names that offer both a measure of safety and modest growth.

The REAL Reason Trump is Invading Iran (Ad)

For a moment…

Forget about Trump’s ties to Israel.

Forget about reports of Iran’s nuclear program.

Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.

Click here to find out what it is.tc pixel

It's a tricky combination, but the healthcare sector is well positioned to deliver it — thanks to an aging population and steady utilization of services. That can create opportunities when strong companies briefly pull back from the sector.

This article highlights three such names. Each has a mix of operational strength, earnings power, and attractive valuations. More importantly, each is tied to a business model that benefits from ongoing demand for medical care, even when the labor backdrop is uneven.

HCA Healthcare: A Scaled Leader With Defensive Appeal

HCA Healthcare (NYSE: HCA) owns and operates a network of hospitals and related facilities, including acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's scale gives it leverage in staffing, purchasing, and operations, which can help offset cost pressure.

HCA hit oversold levels in late March but has rallied since the jobs report and now trades near its 50-day simple moving average (SMA). It has pulled back slightly since that bounce, and a consensus price target of $537.73 indicates healthy upside.

HCA chart showing a bounce following a recent jobs report.

Analysts have been raising their price targets after the company’s strong earnings report. The company beat on both the top and bottom lines and issued constructive full-year guidance.

For investors seeking a steadier healthcare rebound, HCA offers a clean profile: defensive demand, operating efficiency, and a long record of execution. Trading at around 17X earnings, it sits at a slight premium to the sector average but remains a compelling buy on pullbacks.

Tenet Healthcare: Momentum and Institutional Support Stand Out

Tenet Healthcare Corp. (NYSE: THC) is a competitor of HCA, and like HCA, THC has shown strong growth over the past year, climbing more than 50%. That performance was backed by solid revenue and earnings gains year over year.

The THC chart looks similar to HCA’s: it touched oversold levels in late March then climbed after the jobs report, bouncing off a level that had acted as support in January.

THC chart displaying a rebound following the jobs report.

Tenet is supported by heavy institutional ownership — over 95% — and that ownership has been active: buying activity has outpaced selling by nearly 2:1 and remained consistent over the last four quarters.

Analysts are bullish on the stock. Even with a 7.4% rally in THC during the five trading days ending April 9, the stock remains roughly 30% below its consensus price target of $250.56.

Universal Health Services: A Turnaround With Digital Upside

Universal Health Services (NYSE: UHS) is another diversified healthcare management company operating a portfolio similar to Tenet and HCA. UHS has a unique catalyst: it recently announced plans to acquire Talkspace (NASDAQ: TALK), which would give the company a meaningful foothold in digital mental health.

UHS is down about 17% in 2026, in part because the company missed on both the top and bottom lines in its recent earnings report, reversing a rally that began in late January. Like the others on this list, UHS bounced off oversold levels in late March and is attempting a recovery.

UHS chart showing a steep drop in early 2026.

Analysts remain constructive, assigning UHS a consensus price target of $232.21, which implies nearly 30% upside. The stock also has about 86% institutional ownership, and buying has consistently outpaced selling over the last four quarters.

Thank you for subscribing to The Early Bird, MarketBeat's 7:00 AM newsletter that covers stories that will impact the stock market each day.
 
This email communication is a paid sponsorship provided by TradeSmith, a third-party advertiser of The Early Bird and MarketBeat.
 
If you have questions about your subscription, please feel free to email our U.S. based support team at contact@marketbeat.com.
 
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
 
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place #620, Sioux Falls, South Dakota 57103-7078. United States..
 
Read More: U.S. has no domestic tungsten - one junior miner may change that 

No comments:

Post a Comment

Trump warns of 'communists,' but here's what democratic socialists are

Democratic socialists like AOC and Zohran Mamdani have made inroads in some cities. Republicans call them communists but the ideologies diff...